[HTML][HTML] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu - Annals of Oncology, 2017 - Elsevier
Background Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of oncology …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

[引用][C] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu, AR Hansen - Annals of Oncology, 2017 - cir.nii.ac.jp
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint
inhibitors: a systematic review | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[HTML][HTML] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - annalsofoncology.org
Background Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

[PDF][PDF] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - researchmgt.monash.edu
Background: Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

[PDF][PDF] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - research.birmingham.ac.uk
Background: Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

[PDF][PDF] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - researchgate.net
Background: Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

[引用][C] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L KHOJA, D DAY, T CHEN, LL SIU… - Annals of …, 2017 - jglobal.jst.go.jp
Tumour- and class-specific patterns of immune-related adverse events of immune
checkpoint inhibitors: a systematic review | Article Information | J-GLOBAL Art J-GLOBAL ID:201702275492362411 …

[PDF][PDF] Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - pure-oai.bham.ac.uk
Background: Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …

Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: A systematic review

L Khoja, D Day, TWW Chen, LL Siu… - Annals of …, 2017 - research.monash.edu
Background: Immune checkpoint inhibitor (ICI) monoclonal antibodies (mAbs) targeting
cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1) or its …